共 41 条
- [21] Rates and reasons of withdrawal from food oral immunotherapy programmes in a paediatric clinicCLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (10): : 845 - 845Gardner, JamesKnight, KatherineSchnitzer, GemmaWillis, HelenFox, AdamDuToit, GeorgeChan, SusanLack, Gideon
- [22] A CLINICAL TRIAL TO EXAMINE THE SAFETY AND EFFICACY OF PEANUT ORAL IMMUNOTHERAPY AT A COMMUNITY BASED FOOD ALLERGY RESEARCH CENTER.ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A14 - A14Nouman, G.Factor, J.Mendelson, L.Lester, M.Lee, J.Sproviero, J.
- [23] The need for change Lessons learned from Food and Drug Administration-approved peanut oral immunotherapyANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 130 (05) : 542 - 543Mustafa, S. ShahzadMack, Douglas P.
- [24] Zéro allergie research clinic: a clinical and research initiative in oral immunotherapy for managing IgE-mediated food allergyALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2024, 20 (01):Tremblay, Benedicte L.Begin, PhilippeGagnon-Brassard, FrederiqueBoucher-Lafleur, Anne-MarieLavoie, Marie-eveMadore, Anne-MarieLavoie, SarahRochefort-Beaudoin, CloeNuncio-Naud, ClaudiaMorin, CharlesParizeault, GuyLaprise, Catherine
- [25] The Effectiveness and Value of Oral Immunotherapy and Viaskin Peanut for Peanut Allergy A Summary from the Institute for Clinical and Economic Review's California Technology Assessment ForumJOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (05): : 620 - 623Tice, Jeffrey A.Guzauskas, Gregory F.Hansen, Ryan N.Herron-Smith, SerinaSegel, CeliaWalsh, Judith M. E.Pearson, Steven D.
- [26] AGE-RELATED FINDINGS FROM THE PEANUT ALLERGY ORAL IMMUNOTHERAPY STUDY OF AR101 FOR DESENSITIZATION (PALISADE) STUDYANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S4 - S4Burks, A.Casale, T.Beyer, K.DuToit, L.Jones, S.Hourihane, J.Shreffler, W.Marcantonio, A.Vereda, A.Zawadzki, R.Vickery, B.Adelman, D.
- [27] Impact of epicutaneous immunotherapy (EPIT) for the treatment of peanut allergy in children and young adults: Follow-up from the consortium for food allergy research (CoFAR) studyALLERGY, 2019, 74 : 800 - 800Jones, S. M.Burks, A. W.Sicherer, S. H.Leung, D. Y.Henning, A. K.Dawson, P.Lindblad, R. W.Scurlock, A. M.Kim, E.Cho, C. B.Berin, C.Davidson, W. F.Sampson, H. A.Wood, R. A.
- [28] Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On StudyJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (05): : 1879 - +Vickery, Brian P.Vereda, AndreaNilsson, Carolinedu Toit, GeorgeShreffler, Wayne G.Burks, A. WesleyJones, Stacie M.Fernandez-Rivas, MontserratBluemchen, KatharinaHourihane, Jonathan O'B.Beyer, KirstenSmith, AlexRyan, RobertAdelman, Daniel C.
- [29] Post hoc analysis examining symptom severity reduction and symptom absence during food challenges in individuals who underwent oral immunotherapy for peanut allergy: results from three trialsAllergy, Asthma & Clinical Immunology, 19Katharina BlumchenAndreas KleinheinzLudger KlimekKirsten BeyerAikaterini AnagnostouChristian VogelbergSergejus ButovasRobert RyanDavid NorvalStefan ZeitlerGeorge Du Toit
- [30] Post hoc analysis examining symptom severity reduction and symptom absence during food challenges in individuals who underwent oral immunotherapy for peanut allergy: results from three trialsALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2023, 19 (01):Blumchen, KatharinaKleinheinz, AndreasKlimek, LudgerBeyer, KirstenAnagnostou, AikateriniVogelberg, ChristianButovas, SergejusRyan, RobertNorval, DavidZeitler, StefanDu Toit, George